Strs Ohio Vaxart, Inc. Transaction History

Strs Ohio

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 24, 2022	SELL	$5.77 - $7.96 $51,352 - $70,844	-8,900 Closed	0 $0
Q3 2021 Oct 22, 2021	BUY	$6.67 - $9.8 $54,694 - $80,360	8,200 Added 1171.43%	8,900 $70,000
Q4 2020 Jan 25, 2021	SELL	$3.5 - $7.98 $37,450 - $85,386	-10,700 Reduced 93.86%	700 $3,000
Q2 2020 Jul 23, 2020	BUY	$1.68 - $8.85 $19,152 - $100,890	11,400 New	11,400 $100,000

110

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $73.4M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.